761 related articles for article (PubMed ID: 32441559)
1. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
Wijdeveld M; Nieuwdorp M; IJzerman R
Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
[TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
4. The Metabolic Role and Therapeutic Potential of the Microbiome.
Olofsson LE; Bäckhed F
Endocr Rev; 2022 Sep; 43(5):907-926. PubMed ID: 35094076
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.
Leshem A; Horesh N; Elinav E
Front Immunol; 2019; 10():1341. PubMed ID: 31258528
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.
Aron-Wisnewsky J; Warmbrunn MV; Nieuwdorp M; Clément K
Gastroenterology; 2021 Jan; 160(2):573-599. PubMed ID: 33253685
[TBL] [Abstract][Full Text] [Related]
7. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
Chambers ES; Preston T; Frost G; Morrison DJ
Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
[TBL] [Abstract][Full Text] [Related]
8. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
Herrema H; IJzerman RG; Nieuwdorp M
Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
[TBL] [Abstract][Full Text] [Related]
10. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella GG; Sannino A; Esposito G; Perrino C
Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota and metabolic disease: current understanding and future perspectives.
Arora T; Bäckhed F
J Intern Med; 2016 Oct; 280(4):339-49. PubMed ID: 27071815
[TBL] [Abstract][Full Text] [Related]
12. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Tea Polyphenols and Intestinal Microbiota in Host Metabolic Diseases from the Perspective of the Gut-Brain Axis.
Yan R; Ho CT; Zhang X
Mol Nutr Food Res; 2020 Jul; 64(14):e2000187. PubMed ID: 32506625
[TBL] [Abstract][Full Text] [Related]
14. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
Du Y; Li X; Su C; Wang L; Jiang J; Hong B
Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
[No Abstract] [Full Text] [Related]
15. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and obesity: Concepts relevant to clinical care.
Dao MC; Clément K
Eur J Intern Med; 2018 Feb; 48():18-24. PubMed ID: 29110901
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions.
de Brito Alves JL; de Oliveira Y; Carvalho NNC; Cavalcante RGS; Pereira Lira MM; Nascimento LCPD; Magnani M; Vidal H; Braga VA; de Souza EL
Pharmacol Res; 2019 Jul; 145():104252. PubMed ID: 31054952
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
Front Immunol; 2020; 11():571731. PubMed ID: 33178196
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota-brain Axis.
Wang HX; Wang YP
Chin Med J (Engl); 2016 Oct; 129(19):2373-80. PubMed ID: 27647198
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota and Disorders of the Central Nervous System.
Vuotto C; Battistini L; Caltagirone C; Borsellino G
Neuroscientist; 2020; 26(5-6):487-502. PubMed ID: 32441219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
